@powerlifting_portagee's MK-677 claims need some correction
Quick answer
MK-677 (ibutamoren) is an orally active ghrelin receptor agonist that stimulates GH secretion and raises IGF-1 levels. Clinical trials have documented improved sleep architecture and lean mass preservation primarily in older or GH-deficient populations, not in healthy trained athletes. Known risks include impaired insulin sensitivity, fluid retention, and elevated fasting glucose, none of which the creator addressed.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @powerlifting_portagee actually say?
A 36-year-old competitive powerlifter explained why he started using MK-677 (also called ibutamoren). His reasons: faster recovery between heavy training sessions, better sleep, improved nail and hair growth, and relief from joint aches. He lifts heavy, he's aging out of easy recovery, and he wants to keep training pain-free. He also acknowledged it disqualifies him from tested powerlifting events. He directed followers to a specific supplier's page to try it themselves.
That last part, the supplier redirect, is the piece that deserves the most scrutiny here. The rest of his claims are at least partially grounded in pharmacology, even if the framing is incomplete. But "go try it out yourself" skips over a lot of important information that someone picking up MK-677 for the first time genuinely needs.
Does the science back this up?
Partially, yes. MK-677 is a ghrelin mimetic and growth hormone secretagogue. It raises IGF-1 and GH pulse amplitude, and there is real clinical data behind some of his claims, though mostly from older adults and clinical populations, not healthy 36-year-old powerlifters.
On sleep: this is probably his strongest claim. A 1997 study by Copinschi et al. published in Sleep found that MK-677 significantly increased REM sleep and sleep quality in healthy young adults. That data is real and reasonably robust for a single-compound study.
On recovery and muscle: a two-year randomized controlled trial by Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism) found MK-677 increased lean body mass in older adults, though gains were modest and came with meaningful side effects including insulin resistance and edema. A 1998 study by Svensson et al. in Journal of Clinical Endocrinology and Metabolism showed IGF-1 increases up to 40% in healthy young males. Higher IGF-1 does support tissue repair signaling, so the recovery angle is biologically plausible, not proven in athletes.
On joint pain relief: there is no direct clinical trial evidence that MK-677 reduces joint pain. Any effect here is likely indirect, through increased IGF-1 and possibly collagen synthesis signaling, but calling it a joint pain solution overstates what we know.
What did they get wrong (or right)?
He got the sleep benefit largely right. That is probably the most evidence-supported claim he made, and credit where it is due, he did not exaggerate it.
He got the recovery framing mostly right in the sense that elevated GH and IGF-1 do support anabolic and repair processes. But the leap from "plausible mechanism" to "I recover faster" is not directly proven in trained athletes at normal MK-677 doses.
The hair and nail growth claim is real but minor. GH and IGF-1 do influence keratin production. This is not a benefit unique to MK-677 and not a reason most people should make a pharmacological decision.
What he got wrong, or at minimum skipped over entirely: MK-677 consistently raises fasting glucose and can worsen insulin sensitivity (Nass et al., 2008). For a powerlifter eating in a caloric surplus, that is not a trivial risk. He also mentioned no water retention, which is a commonly reported side effect that affects training feel and body composition readings. And the supplier redirect, with no discussion of regulatory status, quality control, or side effect profile, is a real problem in a video with 25,000 views.
What should you actually know?
MK-677 is not FDA-approved for any indication. It is classified as a research compound. That means no standardized dosing, no mandatory quality testing, and no regulatory oversight of what is actually in the product you are buying from a third-party supplier. The FDA has taken action against companies selling it as a dietary supplement.
The side effect profile is not benign. Across multiple studies, MK-677 users showed increased fasting glucose, elevated HbA1c in some cases, fluid retention, and appetite increases significant enough to complicate body composition goals. For someone already managing training load and diet carefully, these are real variables.
The clinical trials that do exist used specific populations, older adults with GH deficiency or muscle wasting, not healthy trained athletes. Extrapolating those results to a 36-year-old powerlifter is reasonable as a hypothesis. It is not the same as having evidence.
If you are considering a growth hormone secretagogue for recovery or sleep, that conversation belongs with a licensed clinician who can review your bloodwork, metabolic markers, and training context. A TikTok supplier link is not a substitute for that evaluation.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @powerlifting_portagee's MK-677 claims need some correction, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@powerlifting_portagee's MK-677 claims need some correction is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
MK-677 (ibutamoren) is an orally active ghrelin receptor agonist that stimulates GH secretion and raises IGF-1 levels.
FormBlends verdict
MK-677 (ibutamoren) is an orally active ghrelin receptor agonist that stimulates GH secretion and raises IGF-1 levels. Clinical trials have documented improved sleep architecture and lean mass preservation primarily in older or GH-deficient populations, not in healthy trained athletes. Known risks include impaired insulin sensitivity, fluid retention, and elevated fasting glucose, none of which the creator addressed.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- MK-677 (ibutamoren) is an orally active ghrelin receptor agonist that stimulates GH secretion and raises IGF-1 levels. Clinical trials have documented improved sleep architecture and lean mass preservation primarily in older or GH-deficient populations, not in healthy trained athletes. Known risks include impaired insulin sensitivity, fluid retention, and elevated fasting glucose, none of which the creator addressed.
- MK-677's sleep benefit is its best-supported claim: Copinschi et al. (1997) found significant REM sleep increases in healthy adults given ibutamoren versus placebo.
- IGF-1 elevations of 40% have been documented in young male subjects (Svensson et al., 1998, JCEM), making the recovery rationale biologically plausible but not proven in athletes.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- MK-677's sleep benefit is its best-supported claim: Copinschi et al. (1997) found significant REM sleep increases in healthy adults given ibutamoren versus placebo.
- IGF-1 elevations of 40% have been documented in young male subjects (Svensson et al., 1998, JCEM), making the recovery rationale biologically plausible but not proven in athletes.
- Nass et al. (2008, JCEM) found MK-677 caused increased fasting glucose and insulin resistance in a two-year trial, a risk the creator did not mention.
- MK-677 is not FDA-approved for any indication and is regulated as a research compound, meaning no mandatory purity or dosing standards apply to retail products.
- All existing efficacy trials were conducted in older adults or those with GH deficiency, not healthy trained powerlifters in their 30s, so direct extrapolation has limits.
- Fluid retention is a commonly reported side effect that can affect body weight readings and training comfort, and was not disclosed in the video.
- A supplier redirect without side effect disclosure in a video with 25,000 views creates real informed-consent gaps for viewers who have no clinical guidance.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
powerlifting_portagee · TikTok creator
25.3K views on this video
Reply to @moonbaser my long answer as to why I use Seromax (mk677). Go to @armonadibi’s page if you want to learn more. #seromax #powerlifer #mk677 #thedarkside #gymtok #fitness #hgh #training #peds
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by powerlifting_portagee, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.